StoreGene Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 6

StoreGene General Information

Description

Developer of a clinical genomic operating system designed to revolutionize the way genetic testing is carried out by healthcare organizations across Europe, Asia, and the Middle East. The platform integrates genomic risk assessment with personalized prescriptions, applying the latest genomic discoveries across various disease areas, enabling clinicians to provide patients with contextualized insights for personalized lifestyle choices.

Contact Information

Formerly Known As
Telomon
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Health Foundry Canterbury House
  • 1, Royal Street
  • London SE1 7LL
  • England, United Kingdom
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Biotechnology
Automation/Workflow Software
Business/Productivity Software
Corporate Office
  • Health Foundry Canterbury House
  • 1, Royal Street
  • London SE1 7LL
  • England, United Kingdom

StoreGene Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

StoreGene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Accelerator/Incubator 24-Jun-2026 Completed Generating Revenue
8. Seed Round Completed Generating Revenue
7. Angel (individual) 02-Apr-2024 Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
5. Accelerator/Incubator 08-Nov-2022 Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Grant 01-May-2021 $64.5K Completed Generating Revenue
1. Grant 01-Jan-2020 $59.9K Completed Generating Revenue
To view StoreGene’s complete valuation and funding history, request access »

StoreGene Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary Shares
To view StoreGene’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

StoreGene Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a clinical genomic operating system designed to revolutionize the way genetic testing is carried out by hea
Enterprise Systems (Healthcare)
London, United Kingdom
7 As of 2026

Calgary, Canada
 

Pasadena, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

StoreGene Competitors (3)

One of StoreGene’s 3 competitors is BioAro, a Venture Capital-Backed company based in Calgary, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioAro Venture Capital-Backed Calgary, Canada
Sequencing Venture Capital-Backed Pasadena, CA
Dante Labs Private Equity-Backed New York, NY
You’re viewing 3 of 3 competitors. Get the full list »

StoreGene Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

StoreGene Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bae HQ Accelerator/Incubator
BioIndustry Association Accelerator/Incubator
The Francis Crick Institute Accelerator/Incubator Minority
Innovate UK Government
P4 Precision Accelerator/Incubator
You’re viewing 5 of 6 investors. Get the full list »

StoreGene FAQs

  • When was StoreGene founded?

    StoreGene was founded in 2004.

  • Where is StoreGene headquartered?

    StoreGene is headquartered in London, United Kingdom.

  • What is the size of StoreGene?

    StoreGene has 7 total employees.

  • What industry is StoreGene in?

    StoreGene’s primary industry is Enterprise Systems (Healthcare).

  • Is StoreGene a private or public company?

    StoreGene is a Private company.

  • What is StoreGene’s current revenue?

    The current revenue for StoreGene is .

  • How much funding has StoreGene raised over time?

    StoreGene has raised $2.92M.

  • Who are StoreGene’s investors?

    Bae HQ, BioIndustry Association, The Francis Crick Institute, Innovate UK, and P4 Precision are 5 of 6 investors who have invested in StoreGene.

  • Who are StoreGene’s competitors?

    BioAro, Sequencing, and Dante Labs are competitors of StoreGene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process